The sale of a vast COVID-19 testing lab in the UK is an opportunity to develop the start-up ecosystem in the Midlands region. But what form of repurposing would serve the region best: a general life sciences hub, or a specialist research and innovation centre? Both options have been floated...
Long term cost savings and quality outcomes for the NHS
New findings from Spirit Health’s prescribing change programmes Research released - demonstrating how a prescribing change program can deliver long-term cost efficiencies and improve patient treatment Greater Manchester achieved a significant 29.6% cost reduction in self-monitoring of blood glucose units over the 6 years Outperforming the average cost reduction in...
Upperton announces expansion into sterile drug manufacturing with new £5million GMP facility
Leading UK contract development and manufacturing organisation (CDMO) Upperton Pharma Solutions (Upperton) has announced a £5million investment to expand operations into small-scale sterile fill-finish. After completing the build and qualification of a new 50,000sqft GMP facility during 2023, the UK-based CDMO announces further expansion at its Trent Gateway site to...
Implementation of the Future Regulations – A view on the Roadmap
In this article Medilink Midlands' Head of Connectivity Chris Dyke shares his thoughts on the Implementation of the Future Regulations. In viewing this new document (9 Jan 2024) the first part of Implementation of the Future Regulations provides additional clarity to what has been previously announced i.e. ‘Transitional Arrangements’ and...
Patron Spotlight: Health Innovation East Midlands
Medilink Midlands offers Patronage to prominent organisations within the Midlands that recognise and demonstrate the importance of life sciences to the region, and that appreciate the positive contribution that Medilink makes to the sector through our diverse programme of events and business support activities. Health Innovation East Midlands (formerly East...
Medilink Midlands awarded Investors in People accreditation
Medilink Midlands has been awarded the ‘We invest in people’ standard accreditation by Investors in People, the UK’s leading people management business improvement standard. The accolade means principles and practices around supporting people are in place at Medilink Midlands and everyone understands how to use them to make work better....
Happy New Year and a warm welcome to 2024 from everybody at Medilink Midlands.
We hope you all had an enjoyable time over the holidays and, like us, are keen to see what 2024 has in store. To kick off the year, we wanted to highlight a few dates for your diaries. Firstly, we’re hosting our Annual Business Awards at the Athena, Leicester this...
Registrations open for Venturefest WM 2024
Registration for Venturefest West Midlands 2024 is now open for entrepreneurs and innovators to develop their businesses and meet potential investors. The West Midlands Combined Authority (WMCA) is sponsoring and co-hosting this free event, which offers the opportunity for entrepreneurs, innovators and investors to share ideas for co-operation and collaboration,...
MHRA supports launch of Innovate UK’s first-of-its-kind initiative to fund new Regulatory Science and Innovation Networks
Applications are now open for academic institutions wishing to bid for funding to collaborate with others to establish new Regulatory Science and Innovation Networks (RSINs) in innovative sectors. Launched on Wednesday 13 December by Innovate UK, the Medicines and Healthcare products Regulatory Agency (MHRA) has joined partners across government including...
VACANCY: R&D Tax Consultant at TBAT Innovation
R&D Tax Consultant £30,000 - £42,000/yr (dependent on experience and knowledge) Job Type: Full-time, permanent (Hybrid) About the role Established in 2002, TBAT Innovation is a vibrant niche consultancy with an overarching aim to stimulate and support research and development focused businesses to innovate. Our main service offerings centre around...